Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V
Nat Rev Cancer. 2025; .
PMID: 40038442
DOI: 10.1038/s41568-025-00795-x.
Prahallad A, Weiss A, Voshol H, Kerr G, Sprouffske K, Yuan T
Cancer Res. 2023; 83(24):4130-4141.
PMID: 37934115
PMC: 10722132.
DOI: 10.1158/0008-5472.CAN-23-1127.
Brockley L, Souza V, Forder A, Pewarchuk M, Erkan M, Telkar N
Cancers (Basel). 2023; 15(8).
PMID: 37190212
PMC: 10136462.
DOI: 10.3390/cancers15082275.
Iourov I, Vorsanova S, Yurov Y
Curr Genomics. 2021; 22(2):75-78.
PMID: 34220294
PMC: 8188578.
DOI: 10.2174/1389202922666210219112419.
Aghamir S, Ebrahimi M, Khatami F
Adv J Emerg Med. 2020; 4(1):e10.
PMID: 31938779
PMC: 6955026.
DOI: 10.22114/ajem.v0i0.216.
RNA-seq as a tool for evaluating human embryo competence.
Groff A, Resetkova N, DiDomenico F, Sakkas D, Penzias A, Rinn J
Genome Res. 2019; 29(10):1705-1718.
PMID: 31548358
PMC: 6771404.
DOI: 10.1101/gr.252981.119.
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.
Tan Y, Srivastava S, Won B, Kanteti R, Arif Q, Husain A
Oncogenesis. 2019; 8(9):49.
PMID: 31484920
PMC: 6726628.
DOI: 10.1038/s41389-019-0159-6.
Next-generation sequencing in liquid biopsy: cancer screening and early detection.
Chen M, Zhao H
Hum Genomics. 2019; 13(1):34.
PMID: 31370908
PMC: 6669976.
DOI: 10.1186/s40246-019-0220-8.
A distance-type measure approach to the analysis of copy number variation in DNA sequencing data.
Biswas B, Lai Y
BMC Genomics. 2019; 20(Suppl 2):195.
PMID: 30967117
PMC: 6456939.
DOI: 10.1186/s12864-019-5491-x.
Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer.
Phallen J, Leal A, Woodward B, Forde P, Naidoo J, Marrone K
Cancer Res. 2018; 79(6):1204-1213.
PMID: 30573519
PMC: 6481620.
DOI: 10.1158/0008-5472.CAN-18-1082.
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
Papp E, Hallberg D, Konecny G, Bruhm D, Adleff V, Noe M
Cell Rep. 2018; 25(9):2617-2633.
PMID: 30485824
PMC: 6481945.
DOI: 10.1016/j.celrep.2018.10.096.
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
Mack E, Marquardt A, Langer D, Ross P, Ultsch A, Kiehl M
Haematologica. 2018; 104(2):277-287.
PMID: 30190345
PMC: 6355503.
DOI: 10.3324/haematol.2018.194258.
Liquid Biopsy in the OMICS Era of Tumor Medicine.
Jiang Y, Wang D
Open Access J Biomed Eng Appl. 2018; 1(3).
PMID: 29683140
PMC: 5908475.
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs).
Douville C, Springer S, Kinde I, Cohen J, Hruban R, Lennon A
Proc Natl Acad Sci U S A. 2018; 115(8):1871-1876.
PMID: 29432176
PMC: 5828610.
DOI: 10.1073/pnas.1717846115.
Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A, Bartlett J, Cheng Y, Pasic M, Yousef G
Mol Cancer. 2017; 16(1):80.
PMID: 28410618
PMC: 5391592.
DOI: 10.1186/s12943-017-0644-5.
Emerging concepts in liquid biopsies.
Perakis S, Speicher M
BMC Med. 2017; 15(1):75.
PMID: 28381299
PMC: 5382440.
DOI: 10.1186/s12916-017-0840-6.
Cell-free circulating tumor DNA in cancer.
Qin Z, Ljubimov V, Zhou C, Tong Y, Liang J
Chin J Cancer. 2016; 35:36.
PMID: 27056366
PMC: 4823888.
DOI: 10.1186/s40880-016-0092-4.
Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies.
Heitzer E, Ulz P, Geigl J, Speicher M
Mol Oncol. 2016; 10(3):494-502.
PMID: 26778171
PMC: 5528970.
DOI: 10.1016/j.molonc.2015.12.004.
Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
Pu T, Guo P, Qiu Y, Chen S, Yang L, Sun L
Int J Clin Exp Pathol. 2015; 8(9):10565-74.
PMID: 26617766
PMC: 4637581.
MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma.
Zhang J, Bian Z, Zhou J, Song M, Liu Z, Feng Y
Protein Cell. 2015; 6(9):680-688.
PMID: 26250158
PMC: 4537476.
DOI: 10.1007/s13238-015-0187-8.